Rationale: At present, data regarding refractory pneumothorax treated with video-assisted thoracic surgery (VATS) in combination with extracorporeal membrane oxygenation (ECMO) in critically ill patients with H7N9 pneumonia have never been reported.
Introduction
Up to now, data regarding critically ill patients with H7N9 pneumonia and severe respiratory failure treated with extracorporeal membrane oxygenation (ECMO) have been mentioned previously. [1, 2] However, reports of pulmonary bullae resection with ECMO support in human disease caused by novel influenza A (H7N9) virus have never been described. We herein report a critically ill patient with avian influenza A (H7N9), who was complicated with severe acute respiratory distress syndrome (ARDS), pulmonary bullae, and refractory pneumothorax. In this case, pneumothorax was ultimately cured by the successful combination of ECMO with video-assisted thoracic surgery (VATS) of pulmonary bullae resection, which was first reported in laboratory-confirmed cases of human infection with avian influenza A (H7N9) virus. Patient has provided informed consent for publication of the case.
Case report
A 28-year-old male with a 3-day history of hyperpyrexia, hemosputum, and shortness of breath was admitted to our hospital. A chest computed tomography (CT) scan revealed multiple ground-glass opacities and consolidation in both lungs (Fig. 1) . The test of nasopharyngeal aspirate obtained upon admission was positive for influenza A (H7N9) virus by reverse transcription PCR (RT-PCR). The patient was treated with oseltamivir (150 mg twice daily) on the first day of hospitalization. However, ARDS progressively developed and veno-venous (VV) ECMO (17 Fr cannula in the right internal jugular vein for inflow, 21 Fr cannula in the left femoral vein for outflow) was required on hospital day 5 because of the failure of invasive mechanical ventilation. Due to the emergence of a right pneumothorax on hospital day 10 and a left pneumothorax on hospital day 15, he was treated with bilateral pleural drainage. Unfortunately, the right pneumothorax had a persistent air leak all the time. Due to refractory pneumothorax, select bronchial occlusion (SBO) was performed for several times; however, the patient still failed to improve. Ultimately, VATS was performed based on ECMO support on hospital day 20. The main findings under thoracoscope showed diffuse pulmonary consolidation with a loss of lung elasticity in the right lung ( Fig. 2A ) and 2 giant Medicine pulmonary bullae measuring 3 cm Â 4 cm Â 4 cm and 4 cm Â 4 cm Â 6 cm, respectively, in the lateral segment of right middle lobe (Fig. 2B , green arrows), one of which exhibited an obvious crevasse (Fig. 2C, green arrow) . Then, successful pulmonary bullae resection in the right middle lobe was performed later on ( Fig. 3, green arrows) . The pathological findings of the resected lung tissue showed fibroproliferative changes along with diffuse alveolar damage (Fig. 4) . The air leakage ceased after the operation. The bronchoalveolar lavage fluid (BALF) was negative for influenza A (N9) virus on hospital day 22, but the specimen remained positive for influenza A (H7) virus until 25 days after hospitalization. During the period, several bacterial isolates were cultured from BALF and antimicrobial therapy was administered at the same time. ECMO was removed on hospital day 27 because of a certain amount of improvement in oxygenation and suspicious thrombosis in right internal jugular vein. However, 3 days after the removal of ECMO, there was a rapid decline in lung compliance over the subsequent 6 days. No significant new co-infection was confirmed at that time. The patient's condition deteriorated progressively and finally he developed multiorgan failure (MOF), which was considered to be complicated by refractory hypoxemia due to progressive lung fibrosis. He died 36 days after admission and a limited postmortem biopsy of lung tissue revealed diffuse pulmonary fibrosis, which was in consistent with the clinical manifestation of refractory hypoxemia.
Discussion
The complication of ARDS from critical illness with avian influenza A (H7N9) may develop rapidly within a brief time period and a high-level pressure ventilation support is often required. However, the necessary of mechanical ventilation with high airway pressures and oxygen concentrations with the addition of serious virus infection and co-infection with bacterial isolates can all contribute to severe lung injury and a decline of lung compliance, [3] [4] [5] which may develop the risk of the complication of pneumothorax. Notably, the emergence of pneumothorax can further exacerbate the existing hyoxemia and apparently increase the mortality rate of patients with severe H7N9 pneumonia and ARDS. [6] In the present case, H7N9 virus infection was progressively deteriorated and the ARDS developed rapidly. Then ECMO was required on hospital day 5 (the 8th day after symptom onset). But a right pneumothorax occurred and had a persistent air leak, despite the performance of pleural drainage and SBO. Ultimately, successful combination of ECMO with VATS of pulmonary bullae resection was performed on hospital day 20. The air leakage ceased after the operation. There were no serious intraoperative and postoperative complications. ECMO was stopped 7 days after surgical operation (the 27th day after admission). But 3 days after removal of the cannulae, the patient's condition was aggravated again with a rapid decline in lung compliance. Finally, he developed MOF due to refractory hypoxemia and died on hospital day 36. A postmortem biopsy of lung tissue revealed severe pulmonary interstitial fibrosis which was considered to be the fatal cause due mainly to a lengthy course of H7N9 virus infection. [3] As pneumothorax was considered to be closely related to the prognosis of critically ill patients with H7N9 infection and ARDS, [6] early recognition of this complication and timely intervention may be useful to improve outcome. Despite the patient in our report finally died of very sever pulmonary fibrosis, [3] the successful treatment of refractory pneumothorax by combination of ECMO with VATS still has a great clinical significance, not only for patients with H7N9. That is to say, when refractory pneumothorax in a patient with severe pulmonary dysfunction fails to improve through routine therapy such as pleural drainage, SBO, and so on, combination of ECMO with VATS can be considered as a feasible selection. 
